Health
Leaders in discovery: five USask researchers honoured with top provincial health awards


|
“Dr. Gerdts’ scientific and leadership accomplishments throughout his illustrious career make him most deserving of this award and recognition. We are grateful for his leadership of VIDO, particularly during the challenging times of the COVID-19 pandemic. He was able to grow and strengthen Canada’s pandemic response and was an integral part in creating Canada’s Centre for Pandemic Research,” said USask Vice-President Research Baljit Singh. “We are grateful for his ongoing commitment to our One Health Signature Area of Research and for inspiring the next generation of scientific leaders.”
Beyond his impressive professional achievements of publications and citations, Gerdts has been a mentor and leader in One Health, which recognizes the integral connections between human, animal, and environmental health. At the institutional level, he has been a champion for One Health as a signature area of research at USask. On the international stage, he co-led the Natural Sciences and Engineering Research Council of Canada (NSERC)-funded Integrated Training Program in Infectious Diseases, Food Safety and Public Policy, training more than 200 young researchers from 15 countries.
“This award is recognition of the many colleagues and collaborators I have worked with over the years, including an outstanding group of individuals here at VIDO,” said Gerdts. “I am excited to continue to develop solutions for emerging diseases of humans and animals. The support from SHRF and other funders over the years has helped to make this vision reality.”
With 91 grants totaling more than $117 million as principal investigator, more than $79 million as co-applicant and over $10 million in contract research, Gerdts has led the development of several vaccines and novel adjuvants—ingredients that help create a stronger immune response—for people and animals.
His work helped to develop a universal protocol for vaccination of pregnant women to improve the health of newborn babies, and as a result, pregnant women now routinely receive the pertussis (whooping cough) vaccine to protect their newborns against the disease. Gerdts’ research focusing on the fetal immune system development was published in Nature Medicine, and his work on a single-immunization vaccine platform for neonates continues with research into a vaccine for pertussis and respiratory syncytial (RSV), which is undergoing production optimization so it can be ready for production in VIDO’s manufacturing facility and used in human clinical trials.
Under his leadership VIDO has experienced enormous growth, including the completion of its vaccine manufacturing facility that strengthens Canada’s production capacity, positioning VIDO as Canada’s Centre for Pandemic Research. He has also played an integral role in drawing top talent from around the globe to work and live in Saskatchewan, while at the same time elevating the province’s scientific reputation.
Since the beginning of the pandemic, Gerdts has demonstrated creative thinking and a keen ability to successfully bring together funders and interdisciplinary collaborators. His over 250 media interviews and presentations about COVID-19 are examples of his skills as a trusted scientific communicator.
Gerdts is among five USask researchers recognized by the provincial funding agency as part of its annual Santé Awards honouring health research excellence in Saskatchewan.
“We are proud of our researchers who have received these prestigious awards,” said Singh. “They are confronting the world’s greatest challenges head on through creativity and collaboration. Their collective impact includes discoveries for improved mental health and wellness, hope for new treatments for drug-resistant infections, and the expertise that will influence how our decision-makers will shape an accessible and culturally responsive healthcare system for the people of Saskatchewan.”





Health
‘Worsening spread’ of deadly fungal infection raising alarm in U.S. – Global News
Cases of a drug-resistant infection caused by the fungus Candida auris are on the rise in the United States, according to new data from the Centers for Disease Control and Prevention (CDC). The fungal infection has proved deadly, especially for those with compromised immune systems, and has demonstrated an ability to spread easily in health-care settings.
The CDC data was published Monday in the Annals of Internal Medicine, amid an outbreak of fungal infections in long-term care facilities in Mississippi. The U.S. health agency found that cases of C. auris increased 95 per cent from 2020 to 2021 following a 44 per cent increase the year prior.
Preliminary figures estimate that there were 2,377 active C. auris infections across the U.S. in 2022, with 5,754 “colonization” cases. A colonization case denotes when a person has evidence of the fungus in their body without signs of an active infection.
Map showing the distribution of C. auris infections in the U.S. in 2022.
CDC
C. auris, a type of yeast that can infect the bloodstream, is resistant to multiple anti-fungal drugs and is estimated to kill about 40 per cent of people who become infected, according to Health Canada. Even when patients survive, they can remain “colonized” with the fungus for years after treatment, the CDC says, and potentially pass it along unsuspectingly.
These fungal infections are of most concern to people who have been hospitalized for long periods of time, are at high risk of infection, or have medical implants. The organism often causes no symptoms in healthy people.
C. auris was first detected in the U.S. in 2016, though case numbers remained low until the “dramatic increase in 2021,” the CDC report reads. The fungus was first discovered in 2009 in Japan and has since caused outbreaks in numerous countries around the world.
Rising cases of C. auris infections, “especially in the most recent years, are really concerning to us,” said the study’s lead author, Dr. Meghan Lyman, chief medical officer in the CDC’s Mycotic Diseases Branch. “We’ve seen increases not just in areas of ongoing transmission, but also in new areas.”
“There’s still a lot to learn about colonization patterns,” Lyman said. “While (medicine) may treat the infection, we don’t have evidence that it completely eliminates C. auris from their body.”
More on Health
Between 2012 and 2021, there were 31 cases of C. auris found in hospitalized patients in Canada, according to data from the National Microbiology Laboratory and Canadian Nosocomial Infection Surveillance Program.
The CDC’s warnings come as Mississippi battles an outbreak of the fungus.
At least 12 people in the state have been infected with the fungus with four “potentially associated deaths,” said Tammy Yates, spokesperson for the Mississippi State Department of Health. Both those numbers doubled since an earlier update on the outbreak in January. The first cases were noticed in the state last year in November.
Transmission of the infections occurred in two long-term care homes, with Yates noting that “multi-drug resistant organisms such as C. auris have become more prevalent” in such facilities and among “highest risk individuals.”
The World Health Organization ranked C. auris as one of the worst fungal threats facing humanity today, given its high mortality rate and resistance to treatment. Recent research suggests that serious fungal infections as a whole affect 300 million people worldwide and more than 1.5 million die from them each year.
Read more:
Nitroglycerin spray helps Canadians with heart conditions, but the medication is in short supply
Dr. Waleed Javaid, director of infection prevention and control at Mount Sinai Downtown in New York, said that the new CDC data on C. auris is “worrisome.”
“But we don’t want people who watched The Last of Us to think we’re all going to die,” Javaid said. “This is an infection that occurs in extremely ill individuals who are usually sick with a lot of other issues.”
Global News has reached out to Health Canada for further comment on the current status of C. auris infections in the country.
© 2023 Global News, a division of Corus Entertainment Inc.
Health
Report calls for restricting food marketing to kids – CP24


A new report that looks at the prevalence of marketing to children inside grocery stores and restaurants suggests regulation is needed to help reduce unhealthy food temptations.
The report, funded by Heart and Stroke and published on Tuesday, audited displays at more than 2,000 restaurants and 800 stores across Canada and says children may be bombarded with messages that make junk food seem appealing.
Researchers found nearly 53 per cent of stores had “junk food power walls” at checkout aisles, which it says are prime areas to market to kids because products are placed within their reach.
The research said that placement encourages “pester power” — when children nag or pester their parents to make impulse purchases.
“Parenting is hard enough without having to deal with environments that are explicitly designed to get our kids pestering us for junk food that’s not supportive of their health,” said Leia Minaker, the author of the report and an associate professor at the University of Waterloo.
“We’re set up to fail by the stores and the restaurants that we go into,” Minaker said.
“It’s really hard to make healthy choices for your kids in this context.”
Designs and themes such as “magic, adventure and zoo animals” are also commonly seen in beverage and ice cream fridges, Minaker said.
The report comes as Bill C-252 for “prohibition of food and beverage marketing directed at children” is under consideration by the House of Commons Standing Committee on Health.
“Given the high proportion of child-directed marketing observed in both stores and restaurants in this Canadian research, it’s clear that policies aimed to restrict marketing of unhealthy food and beverages to kids – something long promised by the federal government – should include point-of-sale locations,” said Doug Roth, CEO of the Heart and Stroke Foundation in a news release.
Stores can help by creating “healthy checkout policies,” where checkout aisles wouldn’t feature junk food and sugary drinks, the report said.
Prohibiting toy giveaways with unhealthy children’s meals in restaurants could also help reduce consumption of unhealthy food, it said.
The Retail Council of Canada (RCC) said it “questions” the report’s findings, including how often certain types of advertising displays are directed at children.
“(That) seems to be offside for us,” said Michelle Wasylyshen, spokeswoman for the council, in an email on Tuesday afternoon.
“The focus should not be on retail, but on the national and global supplier brands that own and sell these products across a variety of channels since they have control over packaging and design and ultimately advertising,” she said.
“RCC has been working closely with Health Canada and other stakeholders on this and related issues.”
A spokesperson for Ad Standards, the Canadian self-regulatory organization for the advertising industry, said they couldn’t comment specifically on the report.
But they directed The Canadian Press to the Code for the Responsible Advertising of Food and Beverage Products to Children, which restricts advertising of products that don’t meet certain nutritional standards to children under 13 years of age.
Ad Standards will begin administering the code later this year, spokeswoman Jessica Yared said in an email.
But according to the code, the restrictions don’t apply to many point-of-sale marketing tactics, including “displays, in-store flyers, posters, menus, menu boards and other on-premises communications and material about a food or beverage product.”
However, those marketing media “may not include language that directly urges a child to buy the product, or directly urge a child to ask another person to buy it for them,” Yared said.
This report by The Canadian Press was first published March 21, 2023.
Canadian Press health coverage receives support through a partnership with the Canadian Medical Association. CP is solely responsible for this content.
Health
Media Advisory: Update on Students with Incomplete Immunization Records – Windsor-Essex County Health


Issued: Wednesday, March 22, 2023 | 10:00 a.m. | Windsor-Essex County
As of March 22, 2023, there are 892 elementary school students suspended due to missing vaccinations as required by the Immunization of School Pupils Act (ISPA) R.S.O.1990 or immunization records that have not yet been submitted to the Windsor-Essex County Health Unit (WECHU). The WECHU will continue to offer clinics daily. Please note that if your child is ill, they will not be immunized, please wait to bring your child to be immunized when they are well.
To have the child’s suspension order lifted, parents/guardians must do one or more of the following so that their child’s immunization is up to date:
- Book an appointment for their child to receive the missing vaccines or provide a valid exemption from their Health Care Provider. Have their healthcare provider fax the child’s updated immunization records to the WECHU @ 519-258-7288.
- Bring their child’s immunization record to the WECHU Windsor or Leamington location
- Update their child’s record at immune.wechu.org (must upload proof).
- Attend a WECHU walk-in clinic. For more details, visit wechu.org/getimmunized.
Once the student’s record is up to date with the WECHU, the student may return to school.
-
Tech19 hours ago
Developer release candidates for tvOS 16.4 & watchOS 9.4 are out
-
Investment21 hours ago
UBS set for talks with Michael Klein to terminate Credit Suisse investment bank deal
-
News15 hours ago
The Losani Family Foundation celebrates 10 years of giving back
-
Art18 hours ago
Daniel Sundahl creates memorial portraits for fallen EPS officers
-
Health20 hours ago
Report calls for restricting marketing to kids in grocery stores, restaurants
-
Economy20 hours ago
Why We Shouldn’t Expect the Russian Economy to Collapse Tomorrow
-
Science20 hours ago
How to Break the Universe and Other Adventures in UMass Astronomy
-
Tech20 hours ago
Diablo 4: Blizzard Says ‘Beta’ Has Become A ‘Twisted Word’ And I’m Calling Shenanigans